Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection

Affiliations

¹ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Institute of Hematology, Zhejiang University, Hangzhou, 31003, Zhejiang, PR China.
² Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Malignant Lymphoma Diagnosis and Therapy Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Institute of Hematology, Zhejiang University, Hangzhou, 31003, Zhejiang, PR China.
³ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China.
⁴ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Malignant Lymphoma Diagnosis and Therapy Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Institute of Hematology, Zhejiang University, Hangzhou, 31003, Zhejiang, PR China. Electronic address: youliangshun@zju.edu.cn.

Qingqing Lin et al. J Microbiol Immunol Infect. 2020 Oct.

. 2020 Oct;53(5):821-822.

doi: 10.1016/j.jmii.2020.03.015. Epub 2020 Mar 25.

¹ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Institute of Hematology, Zhejiang University, Hangzhou, 31003, Zhejiang, PR China.
² Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Malignant Lymphoma Diagnosis and Therapy Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Institute of Hematology, Zhejiang University, Hangzhou, 31003, Zhejiang, PR China.
³ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China.
⁴ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Malignant Lymphoma Diagnosis and Therapy Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, PR China; Institute of Hematology, Zhejiang University, Hangzhou, 31003, Zhejiang, PR China. Electronic address: youliangshun@zju.edu.cn.

No abstract available

Figures

1. Markus H., Hannah K.W., Nadine K., Marcel M., Christian D., Stefan P. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020 doi: 10.1101/2020.01.31.929042. published online Jan 31. - DOI
1. Liu W., Fontanet A., Zhang P.H., Zhan L., Xin Z.T., Baril L. Two-Year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis. 2006;193:792–795. - PMC - PubMed
1. Cao W.C., Liu W., Zhang P.H., Zhang F., Richardus J.H. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357:1162–1163. - PubMed
1. Wu L.P., Wang N.C., Chang Y.H., Tian X.Y., Na D.Y., Zhang L.Y. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–1564. - PMC - PubMed
1. Tang F., Quan Y., Xin Z.T., Wrammert J., Ma M.J., Lv H. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186:7264–7268. - PubMed